Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping (EGM) technology, today announced new findings presented at the Advances in Genome Biology and Technology (AGBT) 2026 meeting. The data ...

Bionano Symposium 2026 continues with Day 3: OGM Making its Mark in Constitutional Genetic Disorders on February 25, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...

It’s called a pangenome, and it could explain the DNA that makes each of us unique. The joke about the Human Genome Project is how many times it’s been finished, but not actually. The first time was ...

Bionano Genomics and Greenwood Genetic Center have announced a study published in Genome Research, marking the first use of optical genome mapping (OGM) to explore the genetic factors behind neural ...

Join us for an installment of our Bionano In Motion webinar series as our speakers delve into immunotherapies and the emerging role of optical genome mapping (OGM) in assessing genome integrity as ...

A phase II study of hyper-CVAD with blinatumomab (blina) and inotuzumab ozogamicin (INO) for newly diagnosed Philadelphia chromosome (Ph)–negative B-cell acute lymphoblastic leukemia (ALL).

Bionano Genomics, Inc. announced a groundbreaking study published in Modern Pathology, which highlights the effectiveness of optical genome mapping (OGM) in detecting bone and soft tissue tumors. This ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 1 of the Bionano Symposium 2026 entitled Advancements in Hematologic Malignancies with Optical Genome Mapping (OGM).

Technology that enables an unprecedented, high-resolution look for all structural variants in our genes that are known to cause cancer can outperform standard tests used today for common blood cancers ...

Einkorn (Triticum monococcum) was the first wheat species domesticated by humans, around 10,000 years ago, playing an important role in the establishment of agriculture in the Middle East. Now, ...